Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Oxford Drug Design Limited”

3 pharma patents match "Oxford Drug Design Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "Oxford Drug Design Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “Oxford Drug Design Limited” · 30,257 patents in full index Clear search

  1. US 12247004

    2-amino-N-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic use

    Oxford Drug Design Limited · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  2. US 11802110

    2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase

    Oxford Drug Design Limited · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  3. US 11072581

    N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors

    Oxford Drug Design Limited · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted